UBS Group: National Health Investors NHI Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 38.1 M | Compra |
580,667
+184,438
| +47% | +USD 13.5 M | 0.01% | 1966 |
|
|
2026
Q2 | USD 30.2 M | Compra |
396,229
+268,595
| +210% | +USD 20.6 M | ﹤0.01% | 2256 |
|
|
2026
Q1 | USD 10.3 M | Venta |
127,634
-69,884
| -35% | -USD 5.82 M | ﹤0.01% | 3307 |
|
|
2025
Q4 | USD 15.1 M | Compra |
197,518
+6,984
| +4% | +USD 536 k | ﹤0.01% | 2872 |
|
|
2025
Q3 | USD 15.1 M | Compra |
190,534
+3,691
| +2% | +USD 276 k | ﹤0.01% | 2873 |
|
|
2025
Q2 | USD 13.1 M | Venta |
186,843
-13,408
| -7% | -USD 982 k | ﹤0.01% | 2820 |
|
|
2025
Q1 | USD 14.8 M | Compra |
200,251
+97,534
| +95% | +USD 6.88 M | ﹤0.01% | 2644 |
|
|
2024
Q4 | USD 7.12 M | Compra |
102,717
+1,204
| +1% | +USD 91.6 k | ﹤0.01% | 3439 |
|
|
2024
Q3 | USD 8.53 M | Compra |
101,513
+40,454
| +66% | +USD 3.12 M | ﹤0.01% | 2520 |
|
|
2024
Q2 | USD 4.14 M | Venta |
61,059
-20,608
| -25% | -USD 1.32 M | ﹤0.01% | 3051 |
|
|
2024
Q1 | USD 5.13 M | Venta |
81,667
-4,547
| -5% | -USD 256 k | ﹤0.01% | 2946 |
|
|
2023
Q4 | USD 4.82 M | Compra |
86,214
+21,479
| +33% | +USD 1.14 M | ﹤0.01% | 2826 |
|
|
2023
Q3 | USD 3.32 M | Venta |
64,735
-26,801
| -29% | -USD 1.4 M | ﹤0.01% | 2960 |
|
|
2023
Q2 | USD 4.8 M | Compra |
91,536
+57,536
| +169% | +USD 2.97 M | ﹤0.01% | 2635 |
|
|
2023
Q1 | USD 1.75 M | Venta |
34,000
-40,943
| -55% | -USD 2.23 M | ﹤0.01% | 3568 |
|
|
2022
Q4 | USD 3.91 M | Compra |
74,943
+3,267
| +5% | +USD 179 k | ﹤0.01% | 2732 |
|
|
2022
Q3 | USD 4.05 M | Venta |
71,676
-11,386
| -14% | -USD 718 k | ﹤0.01% | 2548 |
|
|
2022
Q2 | USD 5.04 M | Venta |
83,062
-12,000
| -13% | -USD 683 k | ﹤0.01% | 2374 |
|
|
2022
Q1 | USD 5.61 M | Venta |
95,062
-7,084
| -7% | -USD 403 k | ﹤0.01% | 2428 |
|
|
2021
Q4 | USD 5.87 M | Venta |
102,146
-21,060
| -17% | -USD 1.17 M | ﹤0.01% | 2653 |
|
|
2021
Q3 | USD 6.59 M | Compra |
123,206
+46,235
| +60% | +USD 2.89 M | ﹤0.01% | 2392 |
|
|
2021
Q2 | USD 5.16 M | Venta |
76,971
-20,580
| -21% | -USD 1.44 M | ﹤0.01% | 2648 |
|
|
2021
Q1 | USD 7.05 M | Compra |
97,551
+4,773
| +5% | +USD 333 k | ﹤0.01% | 2277 |
|
|
2020
Q4 | USD 6.42 M | Venta |
92,778
-8,585
| -8% | -USD 546 k | ﹤0.01% | 2213 |
|
|
2020
Q3 | USD 6.11 M | Compra |
101,363
+31,784
| +46% | +USD 1.96 M | ﹤0.01% | 2016 |
|
|
2020
Q2 | USD 4.22 M | Venta |
69,579
-31,099
| -31% | -USD 1.71 M | ﹤0.01% | 2181 |
|
|
2020
Q1 | USD 4.98 M | Venta |
100,678
-32,754
| -25% | -USD 2.49 M | ﹤0.01% | 1936 |
|
|
2019
Q4 | USD 10.9 M | Compra |
133,432
+34,848
| +35% | +USD 2.85 M | ﹤0.01% | 1884 |
|
|
2019
Q3 | USD 8.12 M | Compra |
98,584
+36,772
| +59% | +USD 2.99 M | ﹤0.01% | 1935 |
|
|
2019
Q2 | USD 4.82 M | Compra |
61,812
+29,264
| +90% | +USD 2.27 M | ﹤0.01% | 2356 |
|
|
2019
Q1 | USD 2.56 M | Venta |
32,548
-17,958
| -36% | -USD 1.43 M | ﹤0.01% | 2783 |
|
|
2018
Q4 | USD 3.82 M | Compra |
50,506
+8,333
| +20% | +USD 628 k | ﹤0.01% | 2415 |
|
|
2018
Q3 | USD 3.19 M | Compra |
42,173
+8,099
| +24% | +USD 618 k | ﹤0.01% | 2765 |
|
|
2018
Q2 | USD 2.51 M | Venta |
34,074
-35,930
| -51% | -USD 2.54 M | ﹤0.01% | 2961 |
|
|
2018
Q1 | USD 4.71 M | Compra |
70,004
+714
| +1% | +USD 48.8 k | ﹤0.01% | 2371 |
|
|
2017
Q4 | USD 5.22 M | Compra |
69,290
+19,013
| +38% | +USD 1.48 M | ﹤0.01% | 2316 |
|
|
2017
Q3 | USD 3.89 M | Compra |
50,277
+9,047
| +22% | +USD 708 k | ﹤0.01% | 2471 |
|
|
2017
Q2 | USD 3.26 M | Venta |
41,230
-2,171
| -5% | -USD 164 k | ﹤0.01% | 2530 |
|
|
2017
Q1 | USD 3.15 M | Compra |
43,401
+15,918
| +58% | +USD 1.17 M | ﹤0.01% | 2506 |
|
|
2016
Q4 | USD 2.04 M | Compra |
27,483
+4,779
| +21% | +USD 351 k | ﹤0.01% | 2893 |
|
|
2016
Q3 | USD 1.78 M | Venta |
22,704
-12,475
| -35% | -USD 981 k | ﹤0.01% | 2947 |
|
|
2016
Q2 | USD 2.64 M | Venta |
35,179
-3,605
| -9% | -USD 250 k | ﹤0.01% | 2534 |
|
|
2016
Q1 | USD 2.58 M | Venta |
38,784
-2,884
| -7% | -USD 178 k | ﹤0.01% | 2445 |
|
|
2015
Q4 | USD 2.54 M | Compra |
41,668
+67
| +0.2% | +USD 4 k | ﹤0.01% | 2582 |
|
|
2015
Q3 | USD 2.39 M | Venta |
41,601
-181
| -0.4% | -USD 10.9 k | ﹤0.01% | 2571 |
|
|
2015
Q2 | USD 2.6 M | Compra |
41,782
+2,316
| +6% | +USD 155 k | ﹤0.01% | 2722 |
|
|
2015
Q1 | USD 2.8 M | Compra |
39,466
+25
| +0.1% | +USD 1.8 k | ﹤0.01% | 2612 |
|
|
2014
Q4 | USD 2.76 M | Compra |
+39,441
| Nuevas | +USD 2.56 M | ﹤0.01% | 2599 |
|
Otros fondos que tienen NHI en su portafolio
Posición de UBS Group en NHI: resumen de T3 2026
UBS Group aumentó su participación en National Health Investors (NHI) en 47% durante T3 2026, al comprar aproximadamente USD 13.5 M y elevar la posición a 580,667 acciones con un valor de USD 38.1 M. La posición representa 0.01% del portafolio y ocupa el puesto #1966.
UBS Group reportó por primera vez una posición en NHI en T4 2014 y desde entonces la ha mantenido en 48 trimestres. Al cierre de T3 2026, 325 fondos que sigue Wall St. Rank mantienen una posición en NHI.
- Al cierre de T3 2026, UBS Group tenía 580,667 acciones de National Health Investors con un valor de USD 38.1 M.
- UBS Group compró 184,438 acciones de National Health Investors en T3 2026, por un monto estimado de USD 13.5 M.
- National Health Investors representó el 0.01% del portafolio de UBS Group en T3 2026 y fue su posición número 1966.
- UBS Group reportó por primera vez una posición en National Health Investors en T4 2014 y desde entonces la ha mantenido en 48 trimestres.
- Al cierre de T3 2026, 325 fondos que sigue Wall St. Rank tenían National Health Investors en su portafolio.
Según el informe 13F de UBS Group correspondiente a T3 2026, presentado el 10 nov 2026.